Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2008
We read with interest the study by Wong et al1 describing the prevalence, treatment, and control of hypertension among US adults with and without cardiovascular (CV) comorbidities. In this study that included a total of 4646 patients, the overall prevalence of hypertension ranged from 23.1% in those without CV comorbidities to 51.8% to 81.8% in those with CV comorbidities. Interestingly, although hypertension treatment rates for diabetes mellitus, stroke, heart failure, and coronary artery disease were higher (83.4%-89.3%) than the rates for those without these conditions (66.5%) (P < .01), control rates for treatment remained poor (23.2%-49.3%) (P < .001 to P = .048).
Barrios V, Escobar C, Echarri R. Concomitance of Cardiovascular Comorbidities in the Hypertensive Population: Not Only in the United States. Arch Intern Med. 2008;168(12):1350-1351. doi:10.1001/archinte.168.12.1350-b